|
|
|
|
Procalcitonin levels Predict Bacteremia in Patients with community-acquired Pneumonia: A prospective cohort trial.
Fabian Mller , MD1, Mirjam Christ-Crain , MD1, Thomas Bregenzer , MD2, Martin Krause , MD3, Werner Zimmerli , MD4, Beat Mueller , MD2,* and Philipp Schuetz , MD1 for the ProHOSP Study Group* 1Department of Internal Medicine, Division of Endocrinology, Diabetes...
|
|
|
Genocea Biosciences Signs Exclusive License Agreement with Childrens Hospital Boston for Novel Streptococcus Pneumoniae Antigens
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, a vaccine discovery and development company, today announced an exclusive worldwide license for developed countries to a portfolio of Streptococcus pneumoniae antigens from Children?s Hospital Boston...
|
|
|
Genocea Biosciences acquires global license for novel Streptococcus pneumoniae antigens from Childrens Hospital Boston
Genocea Biosciences, a vaccine discovery and development company, today announced an exclusive worldwide license for developed countries to a portfolio of Streptococcus pneumoniae antigens from Childrens Hospital Boston.PATH and Genocea retain certain...
|
|
|
Genocea Biosciences Signs Exclusive License Agreement with Children's Hospital Boston for Novel Streptococcus Pneumoniae Antigens
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, a vaccine discovery and development company, today announced an exclusive worldwide license for developed countries to a portfolio of Streptococcus pneumoniae antigens from Childrens Hospital Boston....
|
|
|
Genocea Biosciences Signs Exclusive License Agreement with Children's Hospital Boston for Novel Streptococcus Pneumoniae Antigens
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, a vaccine discovery and development company, today announced an exclusive worldwide license for developed countries to a portfolio of Streptococcus pneumoniae antigens from Childrens Hospital Boston....
|
|
|
Genocea Biosciences Signs Exclusive License Agreement with Childrens Hospital Boston for Novel Streptococcus Pneumoniae Antigens
Companies mentioned in this article: Genocea Biosciences CAMBRIDGE, Mass.-- (BUSINESS WIRE) -- Genocea Biosciences, a vaccine discovery and development company, today announced an exclusive worldwide license for developed countries to a portfolio of...
|
|
|
Genocea Biosciences Signs Exclusive License Agreement with Children's Hospital Boston for Novel Streptococcus Pneumoniae Antigens
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Genocea Biosciences, a vaccine discovery and development company, today announced an exclusive worldwide license for developed countries to a portfolio of Streptococcus pneumoniae antigens from Children's Hospital...
|
|
|
Genocea Biosciences Signs Exclusive License Agreement with Children's Hospital Boston for Novel Streptococcus Pneumoniae Antigens
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, a vaccine discovery and development company, today announced an exclusive worldwide license for developed countries to a portfolio of Streptococcus pneumoniae antigens from Childrens Hospital Boston....
|
|
|
Genocea Biosciences Signs Exclusive License Agreement with Childrens Hospital Boston for Novel Streptococcus Pneumoniae Antigens
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Genocea Biosciences, a vaccine discovery and development company, today announced an exclusive worldwide license for developed countries to a portfolio of Streptococcus pneumoniae antigens from Children's Hospital...
|
|
|
Genocea Biosciences Signs Exclusive License Agreement with Childrens Hospital Boston for Novel Streptococcus Pneumoniae Antigens
CAMBRIDGE, Mass.(BUSINESS WIRE) Genocea Biosciences, a vaccine discovery and development company, today announced an exclusive worldwide license for developed countries to a portfolio of Streptococcus pneumoniae antigens from Childrens Hospital Boston.
|
|
|
Genocea Biosciences Signs Exclusive License Agreement with Childrens Hospital Boston for Novel Streptococcu
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, a vaccine discovery and development company, today announced an exclusive worldwide license for developed countries to a portfolio of Streptococcus pneumoniae antigens from Childrens Hospital Boston....
|
|
|
Gates-linked vaccine group wants $4.3 billion
A global vaccine initiative launched with the help of Bill Gates is seeking $4.3 billion in new funding to ramp up child immunization campaigns against deadly diseases such as hepatitis B, diarrhea and pneumonia in the developing world.A global vaccine...
|
|
|
Genocea Biosciences Signs Exclusive License Agreement with Childrens Hospital Boston for Novel Streptococcu
Genocea Biosciences, a vaccine discovery and development company, today announced an exclusive worldwide license for developed countries to a portfolio of Streptococcus pneumoniae antigens from Childrens Hospital Boston.PATHlong_spaceand Genocea retain...
|
|
|
Acute Kidney Injury Linked to Increased Risk for Mortality Among Patients With Pneumonia
In order to use Medscape, your browser must be set to accept cookies delivered by the Medscape site.To find out how to adjust your browser settings to accept cookies, please click here. Medscape uses cookies to customize the site based on the information...
|
|
|
Gates-linked vaccine group wants $4.3 billion
GENEVA --A global vaccine initiative launched with the help of Bill Gates is seeking $4.3 billion in new funding to ramp up child immunization campaigns against deadly diseases such as hepatitis B, diarrhea and pneumonia in the developing world.The...
|
|
|
Vaccine group seeks $4.3 billion from donors to ramp up immunization campaign for world's poor
By Bradley S.Klapper, The Associated Press GENEVA - A global vaccine initiative launched with the help of Bill Gates is seeking $4.3 billion in new funding to ramp up child immunization campaigns against deadly diseases such as hepatitis B, diarrhea and ...
|
|
|
Vaccine group seeks $4.3 billion from donors to ramp up immunization campaign for worlds poor
GENEVA - A global vaccine initiative launched with the help of Bill Gates is seeking $4.3 billion in new funding to ramp up child immunization campaigns against deadly diseases such as hepatitis B, diarrhea and pneumonia in the developing world.The...
|
|
|
Vaccine group seeks $4.3 billion from donors to ramp up immunization campaign for worlds poor
GENEVA - A global vaccine initiative launched with the help of Bill Gates is seeking $4.3 billion in new funding to ramp up child immunization campaigns against deadly diseases such as hepatitis B, diarrhea and pneumonia in the developing world.The...
|
|
|
Vaccine group seeks $4.3 billion from donors to ramp up immunization campaign for world's poor
A global vaccine initiative launched with the help of Bill Gates is seeking $4.3 billion in new funding to ramp up child immunization campaigns against deadly diseases such as hepatitis B, diarrhea and pneumonia in the developing world.The Geneva-based...
|
|
|
Gates-linked vaccine group wants $4.3 billion
A global vaccine initiative launched with the help of Bill Gates is seeking $4.3 billion in new funding to ramp up child immunization campaigns against deadly diseases such as hepatitis B, diarrhea and pneumonia in the developing world.The Geneva-based...
|
|
|
Vaccine group seeks $4.3 billion from donors to ramp up immunization campaign for worlds poor
GENEVA - A global vaccine initiative launched with the help of Bill Gates is seeking $4.3 billion in new funding to ramp up child immunization campaigns against deadly diseases such as hepatitis B, diarrhea and pneumonia in the developing world.The...
|
|
|
ChildrenEURs Hospital and Genocea Biosciences partner
Genocea Biosciences Inc.and Childrens Hospital Boston have announced an agreement under which Cambridge-based Genocea is licensing a portfolio of Streptococcus pneumoniae antigens developed in a collaboration among Genocea, Childrens and the Seattle...
|
|
|
Gates-linked vaccine group wants $4.3 billion
GENEVA (AP) - A global vaccine initiative launched with the help of Bill Gates is seeking $4.3 billion in new funding to ramp up child immunization campaigns against deadly diseases such as hepatitis B, diarrhea and pneumonia in the developing world.
|
|
|
Bill Gates-linked vaccine group wants $4.3 billion
A global vaccine initiative launched with the help of Bill Gates is seeking $4.3 billion in new funding to ramp up child immunization campaigns against deadly diseases such as hepatitis B, diarrhea and pneumonia in the developing world.The Geneva-based...
|
|
|
Vaccine group seeks $4.3 billion from donors to ramp up immunization campaign for world?s poor
Bradley S.Klapper, THE ASSOCIATED PRESS The Canadian Press, 2010 GENEVA - A global vaccine initiative launched with the help of Bill Gates is seeking $4.3 billion in new funding to ramp up child immunization campaigns against deadly diseases such as...
|
